India is approaching a pivotal moment in the evolution of obesity and metabolic health management, according to Ajanta Pharma. The company has outlined five emerging trends expected to shape the future of obesity care in the country over the coming years, as the ecosystem transitions from reactive treatment toward proactive and long-term disease management.
Growing Burden of Obesity in India
Recent estimates indicate that India is home to one of the world's largest populations living with overweight and obesity. This growing burden is contributing substantially to the rising prevalence of type 2 diabetes, cardiovascular disease, fatty liver disease, and other metabolic disorders. Healthcare systems increasingly recognize obesity as a chronic disease requiring long-term management, driving the need for comprehensive and evidence-based obesity care.
Five Trends Shaping the Future
Ajanta Pharma today presented five trends that will define obesity care in India. Experts recognize that the future of obesity management extends beyond weight reduction alone. Effective care is expected to play a critical role in comprehensive cardiometabolic risk management, including diabetes prevention, cardiovascular health, improvement in obesity-related complications, and long-term enhancement of overall metabolic well-being.
Building the Next Generation of Patient Support
Ajanta Pharma believes these trends highlight the need for comprehensive care models that combine medical innovation with education and patient engagement. To support this evolving landscape, the company is investing in initiatives focused on patient awareness, healthcare professional engagement, and digital support solutions designed to improve treatment adherence and long-term outcomes.
As part of this commitment, Ajanta Pharma has expanded its obesity management portfolio with Ozanta®, a semaglutide-based therapy, while simultaneously exploring patient support programs, expert-led education initiatives, and digital engagement platforms.
"The future of obesity management will be defined not only by scientific advancements but by how effectively we support patients throughout their journey. Building awareness, improving access to information, and strengthening patient engagement will be critical to long-term success," said Mr. Pourus Vakil, President - India Business, Ajanta Pharma.
Company Commitment
As obesity continues to emerge as one of India's most pressing health challenges, Ajanta Pharma remains committed to supporting healthcare professionals and patients through science-led innovation and responsible healthcare initiatives.
About Ajanta Pharma Limited
Ajanta Pharma is a speciality pharmaceutical formulation company with a major focus on branded generic business across India, Asia, and Africa. The company has ground presence in each of these 30+ countries. Many of its products are first to market and are leading in their sub-therapeutic segments. The company also has a presence in the USA in generic business and institution business in Africa. Its state-of-the-art R&D centre is in Mumbai, and it has 7 world-class manufacturing facilities located in India.
